Inbrija 42 MG inhalation cap 60S
Ended Awarded
- Contract number
- SPE2DB25FHXWY
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $1,294
Award facts
- Contract value 100% obligated
- $1,294.24 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for INBRIJA 42 mg inhalation capsules (60-count package) valued at $1,294.24 under a firm fixed price arrangement. The award, issued on September 12, 2025, with an ultimate completion date of October 3, 2025, represents a non-set-aside competitive procurement. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order is issued under the company's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive $999,999,999.00 global pharmaceutical support vehicle running through December 2026.
INBRIJA is an inhaled powder formulation of levodopa indicated for acute, intermittent treatment of off episodes in Parkinson's disease patients. This delivery order exemplifies AmerisourceBergen's role as a critical pharmaceutical distributor supporting military and veteran healthcare systems through the Defense Logistics Agency's medical supply chain. The company's extensive federal contract portfolio demonstrates its capability to fulfill specialized medication requirements across diverse therapeutic domains, with AmerisourceBergen serving as a primary vendor for the Defense Health Agency and other federal healthcare customers seeking reliable access to both brand-name and generic pharmaceutical products.
Quick answers
Who was awarded contract SPE2DB25FHXWY?
SPE2DB25FHXWY was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 12, 2025.
How much is contract SPE2DB25FHXWY worth?
The government has obligated $1,294 on SPE2DB25FHXWY.
Is contract SPE2DB25FHXWY an order under another contract?
Yes. SPE2DB25FHXWY is a delivery order under SPE2DB24D2109, an indefinite delivery contract.
Was contract SPE2DB25FHXWY competed?
The extent of competition for SPE2DB25FHXWY was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award